Damona Pharmaceuticals
Damona Pharmaceuticals, based in Woburn, MA, is focused on developing innovative therapies aimed at reversing cognitive deficits associated with neurological and psychiatric diseases. Their lead program, DPX101, is a positive allosteric modulator targeting the 5GABAA receptor, with promising data indicating its potential to restore connections between brain cells.
The company is dedicated to improving the quality of life for patients suffering from cognitive impairments, as evidenced by their recent advancements, including the clearance of an IND application for a Phase 1 trial of DPX101. Inspired by the Celtic goddess of health and healing waters, Damona's vision emphasizes the healthy flow of cognitive processes, symbolized by a tree representing the brain and its neural connections.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
